DNA Polymerase Alpha Subunit B Is a Binding Protein for Erlotinib Resistance in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Non-small-cell lung carcinoma (NSCLC) covers for almost 85% of all lung cancers and a major contributor to the overall cancer death rate. Erlotinib is used to treat NSCLC via inhibition of epithelial growth factor receptor (EGFR) kinase activity. Despite its high efficacy, recurrence...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Kim, Tae Young, Ji, Eun Sun, Lee, Ju Yeon, Kim, Jin Young, Yoo, Jong Shin, Szasz, A. Marcell, Dome, Balazs, Marko-Varga, Gyorgy, Kwon, Ho Jeong
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564424/
https://ncbi.nlm.nih.gov/pubmed/32933200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092613
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados